Mental health startup eQuoo joins UK’s NHS app library, closes in on seed round
UK-based mental health startup eQuoo has become the only game in the UK’s National Health Service App Library and is set to shortly close it’s seed funding round. The app is an emotional fitness game that aims to teach healthy psychological skills.
The NHS announcement means a UK doctor can now formally refer eQuoo to their patients to improve their mental health and wellbeing.
The app has also now achieved a top rating at ORCHA, the leading health app assessment platform and now has clients including Barmer, the largest insurance company in Germany.
Founder and CEO Silja Litvin says she created the startup because of the mental health crisis. “While working in an NHS Trust for eating and mood disorders I was dismayed about the fact that many of our young clients had to wait months to see us for a measly 6 sessions. Psychologists are not scalable, but apps are, so I decided to make an app. After developing PsycApps, an evidence-based anti-depression app I learned the hard way that mental health apps all struggle with drop off rates of up to 90% in week 1, so we pivoted towards gamification with the launch of eQuoo, as casual games can have a positive mental health effect and intrinsically get players to stick to them.”
A spokesperson for the NHS said: “Approximately 58% GPs across England now have the ability to refer patients directly to Equoo, as its now live on the EMIS App Library. The EMIS App Library is powered by IQVIA’s AppScript® platform, which enables clinical users of the EMIS Web clinical system to find and recommend high quality digital health apps to their patients via text or email, directly from their existing workflow. All apps listed on the platform (including Equoo) have been evaluated under NHS Digital’s digital assessment questions (DAQ) and assessed for their clinical safety, data protection, security and usability.”
Earlier this year the startup also gained scientific backing for its app, Going through a “three arm”, five-week-long, randomized control trial with over 350 participants, with Bosch UK. By contrast Woebot, a highly lauded mental health chatbot startup, went through only a two-week trial with 70 participants.
Results showed “statistically significant increases in wellbeing metrics” and a significant decrease in anxiety when using the app over a timeframe of five weeks.
No comments: